Rhabdomyosarcoma

Indexed in Crossref

22 abstracts matching rhabdomyosarcoma from the meeting's journal supplement, fetched live from Crossref 2026-11-12 11:33 UTC. This is a keyword search, not the complete abstract book.

• 6405
  Small-molecule screening of HiBiT-tagged PAX3::FOXO1 rhabdomyosarcoma cell lines identifies eltanexor as a potent therapeutic agent against fusion-positive rhabdomyosarcoma

  Soumili Dey, Yong Y. Kim, Katrina Jia, Mehal Churiwal et al.
• LB439
  ISWI double-knockout signatures stratify PAX3/7-FOXO1 fusion-positive vs fusion-negative rhabdomyosarcoma

  Ashwaq K. Aljabri
• 4935
  Cell cycle regulation by PAX3-FOXO1 via WEE1 kinase in fusion-positive rhabdomyosarcoma

  Chandra Kaladhar Vemula, JinSeok Park
• 625
  Early tumor priming in Li-Fraumeni Syndrome muscle using a rhabdomyosarcoma model.

  Ashby Kissoondoyal, Paula Rosanna Quaglietta, Brianne Laverty, David Malkin
• 623
  Targeting PAX3::FOXO1 condensates in fusion-positive alveolar rhabdomyosarcoma via disordered-region mimetic peptides.

  Michael Di Martino, Yanghao Zhong, Shasha Chong
• 5950
  Dynamic low-complexity domain interactions of PAX3::FOXO1 mediate endogenous pathological transcriptional hub formation in alveolar rhabdomyosarcoma

  Yanghao Zhong, Michael Di Martino, Shasha Chong
• 3120
  Using genome wide CRISPR screening to identify synthetic lethal targets for overcoming chemoresistance in rhabdomyosarcoma

  Aqsa Mazhar, Qian Wang, Satyanarayana Gadde, Daenikka Ravindraraja et al.
• 645
  Enhancement of antigen presentation restores immune recognition in rhabdomyosarcoma.

  Maya Groff, David Milewski, Hsien-Chao Chou, Vineela Gangalapudi et al.
• 7798
  Embryonal and alveolar rhabdomyosarcoma immunotherapy treatment benefit prediction by CURE AI

  Amit Weiss, Ofir Landau, Tzvi Lederer, Gregory Koushnir et al.
• 7061
  Mechanistic understanding of a novel CBP/p300 inhibitor in fusion-positive rhabdomyosarcoma.

  Md Imdadul H. Khan, Matthew Chang, Yaw Asante, Maya Al-Haddad et al.
• 218
  Zika virus demonstrates oncolytic efficacy against high-risk rhabdomyosarcoma in both in vitro cultures and in vivo murine xenograft models.

  Emily Gearhart, Caroline Finn, Catherine Collins, Rajarajeshwari Venkataraman et al.
• 633
  AVIL’s dependency on YAP as a key mediator of oncogenic activity offers a therapeutic opportunity in rhabdomyosarcoma.

  Martyna Glowczyk-Gluc, Robert Cornelison, Zhongqiu Xie, Julie Fanburg-Smith et al.
• 628
  Investigating the role of BRCA2 in the development of pediatric rhabdomyosarcoma.

  Phillip Adam Weinstein, Elif Asik, Pagna Sok, Cem Ozdemir et al.
• 1569
  Treatment of PAX3-FOXO1 alveolar rhabdomyosarcoma with ICP34.5-armed G47Δ oncolytic herpes simplex virus confers survival benefit when co-administered with anti-Pd1 antibody

  Cole W. Peters, Miriam Valenzuela-Cardenas, Moe Kawakami, Andrew Dinh et al.
• 1155
  High-throughput screening identifies synergistic drug interactions between CDK8/19 and DHFR inhibitors in rhabdomyosarcoma

  Ukhyun Jo, Ying Wu, Lisa M Jenkins, Tapan Kumar Maity et al.
• 3301
  TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma

  Anh Tuan Vuong, Aniket S. Joshi, Anirban Roy, Kavya Mathukumalli et al.
• 4470
  Combination of NAMPT inhibitors plus pyrimidine analog antimetabolites floxuridine and 5-FU impair rhabdomyosarcoma proliferation and survival.

  Jamie Gudyka, Choh Yeung, Senna Munnikhuysen, Christina M. Robinson et al.
• 4638
  Oncolytic herpes simplex virus, M002, increases the antitumor radiation response by decreasing the G2/M arrest in murine rhabdomyosarcoma orthotopic allograft cells

  Maryam G. Shaikh, Nazia Nazam, Morgan L. Brown, Pranava Nande et al.
• CT180
  Safety and efficacy of pucotenlimab combined with standard chemotherapy regimens in the preoperative treatment of pediatric patients with intermediate or high-risk rhabdomyosarcoma: A phase I/II study

  Yi Que, Suying Lu, Feifei Sun, Juan Wang et al.
• 1798
  Nicotinamide phosphoribosyltransferase (NAMPT) inhibitor-resistant rhabdomyosarcoma (RMS) models exhibit alterations in metabolic and genomic profiles

  Ariana Elizabeth Nelson, Abantika Chakraborty, David Bell, Victor J. Collins et al.
• 2758
  PAX3/7::FOXO1 fusion detection and transcriptomic prediction from whole-slide images of rhabdomyosarcoma using attention-based deep learning frameworks: A multi-institutional study.

  Dorsa Ziaei, Hyun Jung, Philip J. Lupo, Pagna Sok et al.
• 3500
  Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit

  Annika Gustafson, Stephanie Nance, Berkley Gryder, Noha A. Shendy et al.